Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines

Molecular Vision

Volumn 14, Issue , 2008, Pages 50-55

  Cools Lartigue, Jonathan J ^a   McCauley, Cristin S ^a   Marshall, Jean Claude A ^a   Di Ccsare, Sebastian ^a   Gregoire, Francois ^a   Antecka, Emilia ^a   Logan, Patrick ^a   Brunier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UVEA MELANOMA;

BLOOD; CELL DIVISION; CELL LINE, TUMOR; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MELANOMA; NEOPLASM CIRCULATING CELLS; TRANSFECTION; UVEAL NEOPLASMS;

EID: 38349048558     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110:962-5.
2. Shields JA. Management of posterior uveal melanoma: past, present, future. Retina 2002; 22:139-42.
3. McLean IW, Saraiva VS, Burnier MN Jr. Pathological and prognostic features of uveal melanomas. Can J Ophthalmol 2004; 39:343-50.
4. Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 2005; 46:2253-7.
5. Toivonen P, Makitie T, Kujala E, Kivela T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci 2004; 45:1-6.
6. Demicheli R, Terenziani M, Valagussa P, Molitemi A, Zambetti M, Bonadonna G. Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 1994; 86:45-8.
7. Marshall JC, Nantel A, Blanco P, Ash J, Cruess SR, Burnier MN Jr. Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin Exp Metastasis 2007; 24:353-62.
8. Fodstad O, Faye R, Hoifodt HK, Skovlund E, Aamdal S. Immunobead-based detection and characterization of circulating tumor cells in melanoma patients. Recent Results Cancer Res 2001; 158:40-50.
9. Ree AH, Engebraaten O, Hovig E, Fodstad O. Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells. Int J Cancer 2002; 97:28-33.
10. Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN Jr. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye 2007; 21:752-9.
11. Bruland OS, Hoifodt H, Saeter G, Smeland S, Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 2005; 11:4666-73.
12. Bjornland K, Flatmark K, Mala T, Mathisen O, Bakka A, Aasen AO, Bergan A, Soreide O, Fodstad O. Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer. J Surg Oncol 2003; 82:224-7.
13. Ulmer A, Schmidt-Kittler O, Fischer J, Ellwanger U, Rassner G, Riethmuller G, Fierlbeck G, Klein CA. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res 2004; 10:531-7.
14. Carrel S, Schreyer M, Gross N, Zografos L. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anticancer Res 1990; 10:81-9.
15. De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstcck G, Danen EH, Jager MJ. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 1995; 62:155-61.
16. Diebold Y, Blanco G, Saornil MA, Fernandez N, Lazaro MC. Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). Curr Eye Res 1997; 16:487-95.
17. Makitie T, Summanen P, Tarkkanen A, Kivela. T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42:1414-21.
18. Faye RS, Aamdal S, Hoifodt HK, Jacobsen E, Holstad L, Skovlund E, Fodstad O. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients. Clin Cancer Res 2004; 10:4134-9.
19. Bernards R, Weinberg RA. A progression puzzle. Nature 2002; 418:823.
20. Van't Veer LJ, Weigelt B. Road map to metastasis. Nat Med 2003; 9:999-1000.
21. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A 2003; 100:15901-5.
22. Marshall JC, Caissie AL, Callejo SA, Antecka E, Burnier Jr MN. Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential. Pathobiology 2004; 71:241-5.
23. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3:537-49.
24. Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S, Nakamura Y. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 2003; 1:485-99.
25. Klein CA. The biology and analysis of single disseminated tumour cells. Trends Cell Biol 2000; 10:489-93.